Influence of changes in cholesterol levels and disease activity on the 10 years cardiovascular risk estimated with different algorithms in rheumatoid arthritis patients-Reference-Cited by-同舟云学术

Influence of changes in cholesterol levels and disease activity on the 10 years cardiovascular risk estimated with different algorithms in rheumatoid arthritis patients

Published:2019-05-29 Issue:9 Volume:79 Page:e104-e104
ISSN:0003-4967
Container-title:Annals of the Rheumatic Diseases
language:en
Short-container-title:Ann Rheum Dis

Author:

Fornaro Marco^ORCID,Cacciapaglia Fabio,Venerito Vincenzo,Lopalco Giuseppe^ORCID,Iannone Florenzo^ORCID

Publisher

BMJ

Subject

General Biochemistry, Genetics and Molecular Biology,Immunology,Immunology and Allergy,Rheumatology

Reference6 articles.

1. EULAR recommendations for cardiovascular disease risk management in patients with rheumatoid arthritis and other forms of inflammatory joint disorders: 2015/2016 update

2. Changes in lipid levels with inflammation and therapy in RA: a maturing paradigm

3. Hippisley-Cox J , Coupland C , Brindle P . Development and validation of QRISK3 risk prediction algorithms to estimate future risk of cardiovascular disease: prospective cohort study. BMJ 2017;357.doi:10.1136/bmj.j2099

4. Development and Validation of Improved Algorithms for the Assessment of Global Cardiovascular Risk in Women

5. Italian cardiovascular mortality charts of the CUORE project: are they comparable with the SCORE charts?

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Estimated 10-year cardiovascular risk in a large Italian cohort of rheumatoid arthritis patients: Data from the Cardiovascular Obesity and Rheumatic DISease (CORDIS) Study Group;European Journal of Internal Medicine;2022-02

2. A Consensus for the Management of Systemic Lupus Erythematosus in Asia;Journal of Clinical Rheumatology and Immunology;2021-05-18

3. The Impact of Biologic Drugs on High-Density Lipoprotein Cholesterol Efflux Capacity in Rheumatoid Arthritis Patients;JCR: Journal of Clinical Rheumatology;2020-12-24

4. THU0257 ESTIMATED 10-YEARS CARDIOVASCULAR RISK IN SYSTEMIC LUPUS ERYTHEMATOSUS PATIENTS: PRELIMINARY RESULTS FROM THE “CARDIOVASCULAR OBESITY AND RHEUMATIC DISEASE (CORDIS)” STUDY GROUP OF THE ITALIAN SOCIETY OF RHEUMATOLOGY.;Annals of the Rheumatic Diseases;2020-06